Market Pulse
All Market Pulse coverage
bioAffinity clears two Nasdaq deficiencies and its hearing is cancelled, leaving about 592,373 shares outstanding
A Nasdaq letter dated Sept. 8 confirmed compliance with both the minimum bid price rule and the rights-and-warrants rule, cancelling a Hearings Panel appearance the company had been pushed into because a reverse split within the prior year disqualified it from any cure period. Two splits in eleven months compound to 450-to-1, above the 250-to-1, two-year threshold written into the same rule.
Two Nasdaq Companies Got Second Bid-Price Windows Running to March 1, 2027. A Third Closed Its Case Today
Alpha Compute and DeFi Technologies each disclosed an additional 180-day period this week, both ending on the same date despite deficiency notices issued three days apart in March. CLPS said on Sept. 4 that it cleared the $1.00 threshold for ten sessions running to Sept. 2.
Edible Garden Regains Nasdaq $1.00 Bid-Price Compliance; the Hearings Panel Keeps Jurisdiction Through Nov. 23
The controlled-environment agriculture company said on Sept. 2 that Nasdaq had confirmed it has regained compliance with the $1.00 minimum closing bid price rule. The company said in July that its closing bid price had stayed at or above $1.00 since a 1-for-45 reverse split took effect on July 13, and the Panel that granted continued listing retains jurisdiction through Nov. 23.
Four Nasdaq companies disclosed late-filing deficiencies in nine days, and the cure clocks run to very different places
Gulf Resources, Breeze Acquisition Corp. II, Shuttle Pharmaceuticals and Netcapital each told investors in the second half of August that Nasdaq had cited them under Listing Rule 5250(c)(1) for overdue periodic reports. The rule is the same in each case; the deadlines the four companies disclosed range from this Monday to February 2027.
Four Micro-Cap Consolidations Across Three Sessions Cut Vision Marine to About 653,000 Shares and Longeveron to About 3.0 Million Class A
Vision Marine, Longeveron and Cycurion each moved this week to consolidate shares and defend a Nasdaq listing. A fourth, OTCQB-quoted GlobalTech, split to try to obtain one. All four left authorized share counts untouched.
Three Reverse Splits Hit the Nasdaq Tape Friday Morning. The market-value rule that would matter most to the companies behind them was approved on July 22, automatically stayed on July 29 and is not in force today.
PMGC Holdings consolidated 1-for-10 at midnight Friday, taking roughly 8.1 million shares to about 809,584; Bit Origin went 1-for-5 at the open and Smartkem 1-for-50 after Thursday's close. None of it moves market value — and a Nasdaq rule approved July 22 that would delist companies below $5 million of market value with no cure period was automatically stayed a week later pending full Commission review.
Six Micro-Caps Report August 17-21 With Listing Clocks and Financing Votes Already Running
While Walmart, Target and Home Depot dominate the week's coverage, InspireMD, Evogene, Datavault AI, Accuray, Unifi and Flux Power all print results the same week. For four of the six, a dated Nasdaq compliance deadline, a shareholder vote or a covenant default is already on the record before the numbers land.
Short interest keeps building on Nasdaq's smallest tier while the big-cap tier unwinds
Nasdaq's July 31 settlement figures, published Wednesday, show Capital Market short interest up almost 10% since mid-June even as the Global Market tier shrank. Days to cover on the small tier has climbed for two straight reports, which says more about disappearing volume than about conviction.
Micro Caps Lead Again as Wednesday's CPI Looms Over a Historic Small-Stock Run
The Russell 2000 outpaced flat large-cap benchmarks Tuesday while the Russell Microcap Index sits on a roughly 59% one-year gain — and an inflation report now stands between the rally and its next leg.